XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
True Up Costs December 2020
Avitide Inc.
Common Stock
Common Stock
Avitide Inc.
Additional Paid-in Capital
Additional Paid-in Capital
True Up Costs December 2020
Additional Paid-in Capital
Avitide Inc.
Accumulated Other Comprehensive Income (Loss)
Accumulated Earnings/(Deficit)
Balance at Dec. 31, 2018 $ 615,568     $ 439   $ 642,590     $ (11,893) $ (15,568)
Balance (in shares) at Dec. 31, 2018       43,917,378            
Net income 21,411                 21,411
Issuance of common stock for debt conversion 198,757     $ 23   198,734        
Issuance of common stock for debt conversion (in shares)       2,316,229            
Reduction of equity component from debt conversion, net of tax (200,079)         (200,079)        
Exercise of stock options and vesting of stock units 1,167     $ 3   1,164        
Exercise of stock options and vesting of stock units (in shares)       339,329            
Issuance of commons stock pursuant to the acquisition 53,938     $ 8   53,930        
Issuance of commons stock pursuant to the acquisition, (in shares)       779,221            
Tax withholding on vesting of restricted stock units (490)     $ 0   490        
Tax withholding on vesting of restricted stock units (in shares)       (5,430)            
Equity component of 0.375% senior convertible notes, net of tax 39,070         39,070        
Proceeds from issuance of common stock, net of issuance costs 320,713     $ 48   320,665        
Proceeds from issuance of common stock, net of issuance costs (in shares)       4,731,531            
Stock-based compensation expense 12,847         12,847        
Balance at Dec. 31, 2019 1,059,768     $ 521   1,068,431     (15,027) 5,843
Balance (in shares) at Dec. 31, 2019       52,078,258            
Translation adjustment (3,134)               (3,134)  
Net income 59,926                 59,926
Exercise of stock options and vesting of stock units 8,140     $ 6   8,134        
Exercise of stock options and vesting of stock units (in shares)       584,589            
Issuance of commons stock pursuant to the acquisition 69,422     $ 4   69,418        
Issuance of commons stock pursuant to the acquisition, (in shares)       372,990            
Proceeds from issuance of common stock, net of issuance costs 297,775     $ 17   297,758        
Proceeds from issuance of common stock, net of issuance costs (in shares)       1,725,000            
Stock-based compensation expense 17,007         17,007        
Balance at Dec. 31, 2020 1,529,150     $ 548   1,460,748     2,085 65,769
Balance (in shares) at Dec. 31, 2020       54,760,837            
Translation adjustment 17,112               17,112  
Net income 128,291                 128,291
Issuance of common stock for debt conversion 2     $ 0   2        
Issuance of common stock for debt conversion (in shares)       7            
Exercise of stock options and vesting of stock units 3,879     $ 3   3,876        
Exercise of stock options and vesting of stock units (in shares)       300,721            
Issuance of commons stock pursuant to the acquisition   $ 145 $ 82,968   $ 2   $ 145 $ 82,966    
Issuance of commons stock pursuant to the acquisition, (in shares)         271,096          
Tax withholding on vesting of restricted stock units (2,897)     $ 0   2,897        
Tax withholding on vesting of restricted stock units (in shares)       (11,204)            
Stock-based compensation expense 27,500         27,500        
Balance at Dec. 31, 2021 1,750,067     $ 553   $ 1,572,340     (16,886) $ 194,060
Balance (in shares) at Dec. 31, 2021       55,321,457            
Translation adjustment $ (18,971)               $ (18,971)